Drug intelligence / Profile preview

solanum nigrum extract

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Solanum nigrum extract is a botanical extract derived from the black nightshade plant (Solanum nigrum Linn.), a medicinal herb of the Solanaceae family native to Southeast Asia and widely distributed across temperate to tropical regions. The extract contains 188 identified chemical constituents, with **steroidal alkaloids** (including solanine, solasonine, and solamargine), **steroidal saponins**, **phenolic compounds**, and **polysaccharides** as the primary bioactive components[1][4]. The extract demonstrates multiple pharmacological activities including **antitumor**, **anti-inflammatory**, **antioxidant**, **antibacterial**, **hepatoprotective**, **neuroprotective**, and **immunomodulatory** effects[1][3]. The mechanism of action involves multiple pathways: inhibition of cell proliferation, induction of apoptosis through caspase pathways, cell cycle arrest, suppression of epithelial-mesenchymal transition (EMT) and metastasis, modulation of various signaling pathways (including MMP-2/MMP-9, TGFβ/Smad, Wnt/β-catenin, PI3K/Akt), and reversal of drug resistance in cancer cells[5]. The extract has been traditionally used in folk medicine systems across Asia, Africa, and Europe to treat various conditions including cancers, inflammatory diseases, liver disorders, fever, diarrhea, and skin conditions[1][3]. Different extraction methods using various solvents (aqueous, ethanolic, methanolic, petroleum ether, chloroform) yield distinct pharmacological profiles[2][5].

Other names
black nightshade extractgarden nightshade extractS. nigrum extract
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)CASP3 (Caspase-3)CASP7 (Caspase-7)CASP9 (Caspase-9)MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)TP53 (Cellular Tumor Antigen p53 R175H)AMPK (Adenosine monophosphate–activated protein kinase)CTNNB1 (Beta-catenin)CASP (Caspase family)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GSK3 (Glycogen synthase kinase 3 beta)NF-κBAKT (RAC-alpha serine/threonine-protein kinase)STAT3 (Signal Transducer and Activator of Transcription 3)TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on solanum nigrum extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on solanum nigrum extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call